Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials

被引：0
|
作者：
Krishna Devarakonda
Kenneth Kostenbader
Michael J. Giuliani
Jim L. Young
机构：
[1] Mallinckrodt Pharmaceuticals,Department of Clinical Pharmacology
[2] Mallinckrodt Pharmaceuticals,Independent Pharmaceuticals Professional
[3] Mallinckrodt Pharmaceuticals,Research and Development
[4] Mallinckrodt Pharmaceuticals,Clinical Affairs and Program Management
[5] Mallinckrodt Inc.,Department of Clinical Pharmacology
来源：
BMC Pharmacology and Toxicology | / 16卷
关键词：
Acetaminophen; Analgesic; Bioavailability; Fasted; Fed; Fixed-dose combination; Hydrocodone bitartrate; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Dose Proportionality and the Effects of Food on Bioavailability of an Immediate-Release Oxycodone Hydrochloride Tablet Designed to Discourage Tampering and Its Relative Bioavailability Compared With a Marketed Oxycodone Tablet Under Fed Conditions: A Single-Dose, Randomized, Open-Label, 5-Way Crossover Study in Healthy Volunteers
    Bass, Almasa
    Stark, Jeffrey G.
    Pixton, Glenn C.
    Sommerville, Kenneth W.
    Zamora, Cynthia A.
    Leibowitz, Mark
    Rolleri, Robert
    CLINICAL THERAPEUTICS, 2012, 34 (07) : 1601 - 1612
  • [42] Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects
    Bernardo-Escudero, Roberto
    Alonso-Campero, Rosalba
    de Jesus Francisco-Doce, Maria Teresa
    Cortes-Fuentes, Myriam
    Villa-Vargas, Miriam
    Angeles-Uribe, Juan
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2012, 37 (04) : 279 - 288
  • [43] Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects
    Roberto Bernardo-Escudero
    Rosalba Alonso-Campero
    María Teresa de Jesús Francisco-Doce
    Myriam Cortés-Fuentes
    Miriam Villa-Vargas
    Juan Ángeles-Uribe
    European Journal of Drug Metabolism and Pharmacokinetics, 2012, 37 : 279 - 288
  • [44] Bioequivalence of Zonisamide Orally Dispersible Tablet and Immediate-Release Capsule Formulations: Results From Two Open-Label, Randomized-Sequence, Single-Dose, Two-Period, Two-Treatment Crossover Studies in Healthy Male Volunteers
    van Maanen, Rob
    Bentley, Darren
    CLINICAL THERAPEUTICS, 2009, 31 (06) : 1244 - 1255
  • [45] Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual FormulationsA Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study
    Kirti Kandhwal
    Surajit Dey
    Shabana Nazarudheen
    Rachna Arora
    Simrit Reyar
    Nageshwar R. Thudi
    Tausif Monif
    Manoj K. Singh
    Shireen Rao
    Clinical Drug Investigation, 2011, 31 : 853 - 863
  • [46] Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study
    Kandhwal, Kirti
    Dey, Surajit
    Nazarudheen, Shabana
    Arora, Rachna
    Reyar, Simrit
    Thudi, Nageshwar R.
    Monif, Tausif
    Singh, Manoj K.
    Rao, Shireen
    CLINICAL DRUG INVESTIGATION, 2011, 31 (12) : 853 - 863
  • [47] Pharmacokinetic Comparison of Sustained- and Immediate-Release Oral Formulations of Cilostazol in Healthy Korean Subjects: A Randomized, Open-Label, 3-Part, Sequential, 2-Period, Crossover, Single-Dose, Food-Effect, and Multiple-Dose Study
    Lee, Donghwan
    Urn, Lay Ahyoung
    Jang, Seong Bok
    Lee, Yoon Jung
    Chung, Jae Yong
    Choi, Jong Rak
    Kim, Kiyoon
    Park, Jin Woo
    Yoon, Hosang
    Lee, Jaeyong
    Park, Min Soo
    Park, Kyungsoo
    CLINICAL THERAPEUTICS, 2011, 33 (12) : 2038 - 2053
  • [48] Pharmacokinetics, Safety, and Bioequivalence of Two Empagliflozin Formulations after Single Oral Administration under Fasting and Fed Conditions in Healthy Chinese Subjects: An Open-label Randomized Single-dose Two-sequence, Two-treatment, Two-period Crossover Study
    Chen, Gang
    Zhang, Dan
    Du, Aihua
    Zhang, Yanan
    Zhang, Ying
    Zhang, Lina
    Zang, Siqi
    Liu, Xiaona
    Wang, Zejuan
    Zhen, Haiqing
    Liu, Yujing
    Yang, Shuya
    Wang, Jin
    PHARMACOTHERAPY, 2020, 40 (07): : 623 - 631
  • [49] Pharmacokinetics and bioequivalence of two formulations of the S-1 (tegafur/gimeracil/oxonate) capsule in Chinese cancer patients under fasting and fed conditions: a multicenter, randomized, open-label, single-dose, double-cycle crossover study
    Lu, Junli
    Lei, Yuyan
    Mo, Yuanyuan
    Wang, Xiangping
    Liu, Wanying
    Yan, Yu
    Yang, Hongying
    Li, Canxia
    Huang, Lifeng
    Shen, Qiuxia
    Wang, Caihong
    Chen, Jingjie
    Chen, Lulu
    Li, Xiaohui
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [50] Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions
    Pentikis, Helen S.
    Adetoro, Nikki
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 543 - 553
12345